Proliferative activity of antigen-specific CD154+ T cells against bacterial and fungal respiratory pathogens in cystic fibrosis decreases after initiation of highly effective CFTR modulator therapy.
第一作者:
Patience N,Eschenhagen
第一单位:
Cystic Fibrosis Section, Klinikum Westbrandenburg, Campus Potsdam, Potsdam, Germany.;HMU Health and Medical University, Potsdam, Germany.;Department of Pediatric Pneumology, Immunology and Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
作者:
DOI
10.3389/fphar.2023.1180826
PMID
37408761
发布时间
2023-07-18
- 浏览0
Frontiers in pharmacology
1180826页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



